US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

8  9  10  11    13    15  16  17  
Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review
6/10/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
TransGenic Inc. (2342) - Financial and Strategic SWOT Analysis Review
6/10/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
6/1/2014 | published by: GBI Research
... research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs'’, which provides in-depth analysis of breast cancer therapeutics market within the eight ...  |  read more...
USD 3,500
Biovest International, Inc. (BVTIQ) - Financial and Strategic SWOT Analysis Review
6/17/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Biotech Business July 2014
7/1/2014 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
USD 25
Biotech Financial Reports July 2014
7/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
USD 25
Chronic Lymphocytic Leukaemia: KOL Insight
5/27/2014 | published by: FirstWord
... radically altering the treatment algorithm. From Roche’s improved anti-CD20 monoclonal antibody Gazyva, to Pharmacyclics/Janssen Biotech’s Imbruvica, the treatment landscape is being transformed. Drivers of change Targeted therapies. Most significantly, KOLs predict that therapies from Roche, ...  |  read more...
USD 4,995
Biopharmaceuticals Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are ...  |  read more...
USD 4,000
Marina Biotech, Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 32
Can new biologic therapies expand the severe asthma market? - Physician Views:
6/3/2014 | published by: FirstWord
... the regulatory and commercial arenas over the next few years. Analysts are suitably expectant, as are developers, with there being some suggestion that the patient population eligible for treatment with these compounds will expand significantly ...  |  read more...
USD 645
Synthetic Biologics, Inc. - Product Pipeline Review - 2014
6/25/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Synthetic Biologics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014
5/30/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Northwest Biotherapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Antibody Partnering Terms and Agreements
6/1/2014 | published by: Current Partnering
... leading companies worldwide. Antibody Partnering Terms and Agreements includes: Trends in antibody dealmaking in the biopharma industry since 2009 Analysis of antibody deal structure Access to headline, upfront, milestone and royalty data Case studies of ...  |  read more...
USD 2,995
Hemispherx Biopharma, Inc. - Product Pipeline Review - 2014
5/30/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Hemispherx Biopharma, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Active Biotech AB - Product Pipeline Review - 2014
5/30/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Active Biotech AB’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Biotechnology Product Manufacturing
6/9/2014 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as Cangene (Canada), CSL (Australia), Merck KGaA (Germany), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France, owns ...  |  read more...
USD 129
GlycoMar Limited - Product Pipeline Review - 2014
5/30/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Fina Biotech - Product Pipeline Analysis, 2014 Update
6/6/2014 | published by: GlobalData
... is a kit to determine the degree of DNA fragmentation in human sperm, using sperm chromatin dispersion (SCD) technique. It produces new tools for monitoring, diagnosis, prognosis and treatment of significant diseases. Fina investments in ...  |  read more...
USD 750
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review
6/4/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Global Genetic Testing Market : Industry Analysis And Market Forecast 2014-2020
6/20/2014 | published by: Mordor Intelligence LLP
... service-driven market to a product-driven market is expected to provide an impetus to the diagnostic companies for the expansion of their operations. Genetic Testing market sales are expected to reach $25 billion annually by 2021 ...  |  read more...
USD 3,250
Nocturia - Pipeline Review, H1 2014
5/30/2014 | published by: Global Markets Direct
... Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Dendreon Partnering 2009-2014
6/24/2014 | published by: Current Partnering
... you require to better understand Dendreon and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
8  9  10  11    13    15  16  17